The anti-angiogenic effect is achieved through the suppression of VEGF expression originating from the tumour, thereby inhibiting the proliferation of endothelial cells and the remodelling of the extracellular matrix into blood vessels and stimulating the immune response through the activation of immune cells [6,7,8]. This evidence concerns the gene VEGFA and neoplasm.